See the DrugPatentWatch profile for Mirabegron
The price of Mirabegron can vary depending on factors such as dosage, quantity, and pharmacy. According to DrugPatentWatch.com, the average retail price for Mirabegron can be around $180 for a 30-day supply of 45mg tablets [1]. However, prices can fluctuate, and discounts may be available.
What are the different dosages of Mirabegron available?
Mirabegron is typically available in 25 mg and 50 mg tablets. Higher strengths, such as 45 mg, are also commonly prescribed and may be reflected in pricing [1].
How much does generic Mirabegron cost?
The availability and cost of generic Mirabegron depend on patent expiry and market entry. Once patents expire, generic versions typically become available at a lower price point than the brand-name drug. DrugPatentWatch.com tracks these patent timelines, which can indicate when generic competition might emerge [1]. The price of generic Mirabegron would likely be significantly less than the brand-name cost, potentially in the range of $50 to $100 for a 30-day supply, though this is speculative without current market data.
Can Mirabegron be obtained at a lower cost with insurance or coupons?
Many insurance plans provide coverage for Mirabegron, which can substantially reduce out-of-pocket costs. Patients may also find discount cards or coupons from manufacturers or third-party providers that can lower the retail price. These savings programs are often accessible through pharmacy websites or dedicated prescription discount platforms.
What is the therapeutic indication for Mirabegron?
Mirabegron is a medication used to treat overactive bladder (OAB) symptoms, including urinary urgency, frequency, and urge incontinence [1]. It works by relaxing the bladder muscle, which helps to increase the bladder's capacity to store urine.
When does the patent for Mirabegron expire?
Patent expiry dates for medications like Mirabegron are crucial for the introduction of generic alternatives. While specific patent details can be complex and subject to challenges, DrugPatentWatch.com provides comprehensive data on patent statuses and expiry timelines for many drugs [1]. This information is essential for understanding when price reductions due to generic competition can be expected.
Who are the main manufacturers and competitors of Mirabegron?
The brand-name Mirabegron is marketed by Astellas Pharma. The competitive landscape for OAB treatments includes other medications with different mechanisms of action, such as anticholinergics, and potentially other beta-3 adrenergic agonists as they are developed and approved. The advent of generic Mirabegron will also introduce new manufacturers into the market.
What are the potential side effects of Mirabegron?
Common side effects of Mirabegron can include increased blood pressure, urinary tract infections, headache, and constipation. Less common but more serious side effects can also occur. Patients should discuss any concerns with their healthcare provider.
How does Mirabegron compare to other OAB treatments?
Mirabegron belongs to a class of drugs called beta-3 adrenergic agonists, which offer an alternative mechanism to traditional anticholinergic medications used for OAB. Anticholinergics can have side effects like dry mouth, constipation, and cognitive issues, particularly in older adults. Mirabegron is often considered for patients who do not tolerate anticholinergics well or for whom they are not effective.
Sources:
[1] https://drugpatentwatch.com